SCHEMBL7202960

SCHEMBL7202960

Cc1ccc(C)n1-c1cccc(CCN)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.41
PDE10A Q9Y233 10/20 0.39
HRH1 P35367 1/20 0.39
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
TAAR1 Q96RJ0 2/20 0.34
KCNH2 Q12809 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
MTOR P42345 1/20 0.33
HRH4 Q9H3N8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2974037 0.84 KCNH2 (0.43) PDE10ANOS1NOS2KCNH2MAPT
SCHEMBL2968640 0.81 KCNH2 (0.53) PDE10ANOS2KCNH2
SCHEMBL2015923 0.80 PDE10A (0.36) IRAK4PDE10AKCNH2KDM4EMEN1
SCHEMBL6501711 0.80 KCNH2 (0.40) PDE10ANOS1NOS2KCNH2
SCHEMBL7798225 0.79 PDE10A (0.37) PDE10ANOS1NOS2KCNH2
SCHEMBL8329772 0.78 NOS2 (0.39) NOS1NOS2
SCHEMBL6500417 0.77 KCNH2 (0.49) KCNH2KDM4EMEN1ALDH1A1MAPT
SCHEMBL18586993 0.77 MAPT (0.45) KDM4EMEN1ALDH1A1MAPTALOX15
SCHEMBL7399754 0.76 KCNH2 (0.37) PDE10AKCNH2
SCHEMBL2965375 0.76 NOS3 (0.35) PDE10ANOS1NOS2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed